Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2007
11/15/2007US20070264336 Hydrophilic/lipophilic polymeric matrix dosage formulation
11/15/2007US20070264319 Transdermal Antiemesis Delivery System, Method and Composition Therefor
11/15/2007US20070264314 Orally administering antispasmodic compound such as dicyclomine and a fiber compound with water at least one hour before a meal and orally administering 1-9 ounces of a baked batter consisting of pecans, sweetener, cloves, nutmeg, cinnamon and egg white 45 minutes after antispasmodic and fiber compounds
11/15/2007US20070264313 Methods and compositions relating to animal dietary acids
11/15/2007US20070264312 Rheologically Modified Edible Oils
11/15/2007US20070264311 Cysteine Protease from Ginger (Zingiber) as a Food Improver and Anti-Inflammatory
11/15/2007US20070264289 Compositions and methods of administering doxepin to mucosal tissue
11/15/2007US20070264285 Compositions Comprising Cationic Microparticles And Hcv B1e2 Dna And Methods Of Use Thereof
11/15/2007US20070264266 Maytansine derivatives having a sterically hindered thiol or disulfide groups, capable of conjugating to cell-binding agents, to form drugs having improved therapeutic efficacy in animal tumor models; antitumor agents
11/15/2007US20070264261 Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
11/15/2007US20070264227 Synthetic Matrix for Controlled Cell Ingrowth and Tissue Regeneration
11/15/2007US20070264198 Tumor necrosis agent
11/15/2007DE19544507B4 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations
11/15/2007DE102007017298A1 New nanoparticles containing nicotine and/or cotinine useful e.g. for cigarette weaning and to treat e.g. attention-deficit hyperactivity disorder, Parkinson's disease, Alzheimer's disease and Binswanger's disease
11/15/2007DE102006022449A1 Verbesserte Eisenoxidgelbpigmente Improved iron oxide yellow pigments
11/15/2007DE102006021784A1 Effektpigmente und deren Verwendung in der Kosmetik und im Lebensmittel- und Pharmabereich Effect pigments and their use in cosmetics and in food and pharmaceutical industries
11/15/2007CA2846817A1 Short interfering ribonucleic acid (sirna) for oral administration
11/15/2007CA2846732A1 Short interfering ribonucleic acid (sirna) for oral administration
11/15/2007CA2651696A1 Modified release tablets comprising tramadol
11/15/2007CA2651329A1 Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
11/15/2007CA2650580A1 A method for delivering a human chorionic gonadotropin (hcg) vaccine for long-acting antibody production
11/15/2007CA2649902A1 Spherical microcapsules comprising glp-1 peptides, their production and use
11/15/2007CA2649627A1 Methods and compositions for remediation of disc herniation by modifying structure
11/14/2007EP1854807A1 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative
11/14/2007EP1854478A1 Nicotine-carrier vaccine formulation
11/14/2007EP1854472A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same
11/14/2007EP1854471A1 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/14/2007EP1854463A1 Release-control composition
11/14/2007EP1854462A1 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids
11/14/2007EP1854460A1 External plaster containing flurbiprofen
11/14/2007EP1854456A1 Pressure-sensitive adhesive base and medical adhesive patch including the pressure-sensitive adhesive base
11/14/2007EP1854455A1 Spherical microcapsules comprising GLP-1 peptides, their production and use
11/14/2007EP1854454A2 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
11/14/2007EP1853322A2 Process for preparing maytansinoid antibody conjugates
11/14/2007EP1853321A2 Insulinotropic agents conjugated with structurally well defined branched polymers
11/14/2007EP1853320A1 Protein-binding anthracyclin peptide derivatives and medicaments comprising the same
11/14/2007EP1853319A1 Use of aromatic flavouring agents with high melting point as solubilizing agents
11/14/2007EP1853310A2 Anti a beta antibody formulation
11/14/2007EP1853303A1 Stabilized compositions for topical administration and methods of making same
11/14/2007EP1853278A1 Glucosamine materials
11/14/2007EP1853275A1 Formulations of pyridoxal -5'-phosphate and methods of preparation
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1853238A2 Pharmaceutical formulations containing 17-allylamino-17-demethoxygeldanamycin
11/14/2007EP1853236A1 Tablets comprising a biologically active substance and an excipient containing calcium carbonate
11/14/2007EP1824485A4 Pharmaceutical formulation for increasing solubility of 10-hydroxycamptothecin compounds in non-aqueous polar solvents
11/14/2007EP1669379B1 3,5-dimethyl-1-adamantyl-ammonium polymeric salts and the use thereof in the form of antiviral agents
11/14/2007EP1648412B1 Microemulsions and its use for preventing airway diseases
11/14/2007EP1469835B1 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
11/14/2007EP1409021B1 Formulation comprising fulvestrant
11/14/2007EP1368048B1 Pharmaceutical composition made of cannabis extracts
11/14/2007EP1362053B1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/14/2007EP1361895B1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/14/2007EP1332145B1 Process for formulation of antibiotic compounds
11/14/2007EP1296651B1 Method of making particles for use in a pharmaceutical composition
11/14/2007EP1237536B1 The use of fluorescent whitening agents
11/14/2007EP1141079B1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
11/14/2007EP0952843B1 Pharmaceutical formulations for sustained drug delivery
11/14/2007EP0587858B2 Protein formulation comprising growth hormone
11/14/2007CN101072589A Conjugates with enhanced cell uptake activity
11/14/2007CN101072588A Liposomes with improved drug retention for treatment of cancer
11/14/2007CN101072581A Therapeutic agents with decreased toxicity
11/14/2007CN101072565A Method and composition for supplementation of nutritional deficiencies in renal patients
11/14/2007CN101072551A Sustained release formulation comprising bisphosphonate
11/14/2007CN101070389A Hollow micro-ball containing phosphazene and preparing method
11/14/2007CN101069744A 流感疫苗组合物 Influenza vaccine composition
11/14/2007CN101069742A Pancreatic kininogenase tablet and preparing method
11/14/2007CN101069741A Medical radiation-ray preventive spray agent
11/14/2007CN101069695A Colon target-positioning preparation for treating colonitis and preparing method
11/14/2007CN101069691A Capsule preparation for treating gastric ulcer and preparing method
11/14/2007CN101069689A External-use medicine for one-time treatment of tinea-like dermatosis
11/14/2007CN101069688A Medicine composition containing theocin-like medicines and vitamin K
11/14/2007CN101069687A Entecavir dispersing tablet and preparing method
11/14/2007CN101069686A Laevo-ornidazole vagina administration preparation, its preparing method and use
11/14/2007CN101069685A Solid drug for oral use
11/14/2007CN101069684A Composition comprising a cholesterol absorption inhibitor, and hmg-coa reductase inhibitor and a stabilizing agent
11/14/2007CN101069681A Injection containing burufen
11/14/2007CN101069678A Soft capsule and preparing method thereof
11/14/2007CN101069677A Pullulan polysaccharide hollow hard capasule and its preparing method
11/14/2007CN101069676A Method for preparing brufen soft capsule
11/14/2007CN100348730C Method for preparing medical collagen protein powder
11/14/2007CN100348640C Preparation method of glycosyl teminated functionalized polycaprolactone with different branch structure
11/14/2007CN100348618C Process for producing hydroxyalkyl starch derivatives
11/14/2007CN100348265C Controlled release composition and method of producing the same
11/14/2007CN100348185C Micropherules containing a pleuromutilin derivative
11/14/2007CN100348179C Prepn process of microcapsule with included anticancer medicine
11/13/2007US7294687 For alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject
11/13/2007US7294646 Indole diterpene natural product and synthetic compound; Potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions related to elevated intraocular pressure in the eye
11/13/2007US7294615 Compounds that associate on the intermolecular level and aggregate bodies that contain them
11/13/2007US7294455 Fixed-dried platelets cross-linked to protein
11/13/2007US7294336 Stabilized liquid anti-RSV antibody formulations
11/13/2007US7294334 Methods and compositions to treat myocardial conditions
11/13/2007US7294328 Calcining a gibbsite-phase aluminum hydroxide; forming the rehydratable alumina powder produced in the presence of water; and maintaining the formed body in the presence of water at 110 to 200 degrees C., to rehydrate the formed body
11/13/2007CA2431586C Antibiotic/benzoyl peroxide dispenser
11/13/2007CA2396159C Novel substituted benzimidazole dosage forms and method of using same
11/13/2007CA2304272C Polymeric microporous film coated subcutaneous implants
11/13/2007CA2301132C Rapidly disintegrating methylcellulose tablets
11/13/2007CA2253257C Receptor for underivatized, aqueous soluble .beta.(1-3)-glucan
11/13/2007CA2251008C Macromolecular complexes for drug delivery
11/08/2007WO2007127844A2 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye
11/08/2007WO2007127665A2 Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
1 ... 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 ... 1712